CPDC Launches Cadena Research, a Radiopharmaceutical Preclinical CRO
Cadena Research empowers radiopharmaceutical innovators by delivering tailored solutions that accelerate the path to clinical translation. Hamilton, Ontario – September 29, 2025 – CPDC, a global leader in the development and commercialization of radiopharmaceuticals, is proud to announce the launch of Cadena Research, a new preclinical contract research organization (CRO) offering specialized support for early-stage drug … Read more